Sala, Abdullatip J.

HRN: 29-33-36  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2026
RIFAXIMIN 200MG (TAB)
07/18/2026
07/31/2026
PO
300mg
BID
Liver Cirrhosis
Checking Initial Appropriateness 
07/21/2026
RIFAXIMIN 200MG (TAB)
07/21/2026
07/30/2026
PO
400 Mg/tab
TID
Liver Cirrhosis W/ Massive Ascites
Remove - Pending Acceptance
07/21/2026
CIPROFLOXACIN 500MG (TAB)
07/21/2026
07/27/2026
PO
500 Mg
BID
Liver Cirrhosis W/ Massive Ascites
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: